Literature DB >> 12036991

Effect of immunosuppression on gene expression in the HSV-1 latently infected mouse trigeminal ganglion.

Shiro Higaki1, Bryan M Gebhardt, Walter J Lukiw, Hilary W Thompson, James M Hill.   

Abstract

PURPOSE: To determine alterations in expression of genes in herpes simples virus (HSV)-1 latently infected mouse trigeminal ganglia (TGs), after treatment with cyclophosphamide and dexamethasone.
METHODS: Scarified corneas of female BALB/c mice were inoculated with HSV-1 strain McKrae. Four weeks after inoculation, cyclophosphamide and dexamethasone were intravenously injected to induce HSV-1 reactivation. Uninfected mice were also treated with the immunosuppressants. Four groups of animals were studied: uninfected, not treated; uninfected, drug treated; latently infected, not treated; and latently infected, drug treated. PolyA+ mRNA from the TGs of each group was reverse transcribed, labeled with 32P, incubated on a 1185-gene array membrane, and analyzed by phosphorimaging. As a comparison and to confirm microarray results, semiquantitative RT-PCR was also performed for selected genes.
RESULTS: The immunosuppressive drugs significantly increased expression of two genes (calpactin 1 light chain and guanine nucleotide-binding protein alpha-stimulating polypeptide [GNAS]) in the ganglia of uninfected mice compared with those in untreated uninfected mice. Ten genes were shown to be significantly increased in the latent TGs of mice treated with immunosuppressants compared with latently infected untreated mice. These genes were prostaglandin E2 receptor EP4 subtype (PTGER4), insulin promoter factor 1 (IPF1), glutathione S-transferase mu2, cyclin D2, peripherin, plasma glutathione peroxidase, methyl CpG-binding protein 2, retinal S-antigen, ErbB2 proto-oncogene, and GNAS. Eight genes were shown to be significantly decreased in the HSV-1 latent TGs treated with the drugs, compared with untreated latently infected mice. These genes were peripheral myelin protein 22, decorin, transcription factor AP-1, dystroglycan 1, myelin protein zero, mitogen-activated protein kinase 3, prothymosin beta 4, and brain lipid-binding protein. The results obtained by semiquantitative RT-PCR were similar to those obtained by microarray analysis.
CONCLUSIONS: Those genes with expression altered by immunosuppressive drug treatment may play an important role in ocular HSV-1 recurrence. Changes in expression of genes in the prostaglandin pathway, a transcription factor, and an enzyme in the cell cycle are considered especially important in HSV-1 reactivation by immunosuppression and are reviewed.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12036991

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  27 in total

1.  Spreading of Alzheimer's disease inflammatory signaling through soluble micro-RNA.

Authors:  Walter J Lukiw; Peter N Alexandrov; Yuhai Zhao; James M Hill; Surjyadipta Bhattacharjee
Journal:  Neuroreport       Date:  2012-07-11       Impact factor: 1.837

2.  NF-кB-regulated micro RNAs (miRNAs) in primary human brain cells.

Authors:  Walter J Lukiw
Journal:  Exp Neurol       Date:  2011-11-23       Impact factor: 5.330

3.  Upregulation of micro RNA-146a (miRNA-146a), a marker for inflammatory neurodegeneration, in sporadic Creutzfeldt-Jakob disease (sCJD) and Gerstmann-Straussler-Scheinker (GSS) syndrome.

Authors:  W J Lukiw; P Dua; A I Pogue; C Eicken; J M Hill
Journal:  J Toxicol Environ Health A       Date:  2011

4.  Decreased reactivation of a herpes simplex virus type 1 (HSV-1) latency-associated transcript (LAT) mutant using the in vivo mouse UV-B model of induced reactivation.

Authors:  Lbachir BenMohamed; Nelson Osorio; Ruchi Srivastava; Arif A Khan; Jennifer L Simpson; Steven L Wechsler
Journal:  J Neurovirol       Date:  2015-05-22       Impact factor: 2.643

5.  Prior Corneal Scarification and Injection of Immune Serum are Not Required Before Ocular HSV-1 Infection for UV-B-Induced Virus Reactivation and Recurrent Herpetic Corneal Disease in Latently Infected Mice.

Authors:  Lbachir BenMohamed; Nelson Osorio; Arif A Khan; Ruchi Srivastava; Lei Huang; John J Krochmal; Jairo M Garcia; Jennifer L Simpson; Steven L Wechsler
Journal:  Curr Eye Res       Date:  2015-09-23       Impact factor: 2.424

6.  Differential expression of miRNA-146a-regulated inflammatory genes in human primary neural, astroglial and microglial cells.

Authors:  Yuan Yuan Li; Jian Guo Cui; Prerna Dua; Aileen I Pogue; Surjyadipta Bhattacharjee; Walter J Lukiw
Journal:  Neurosci Lett       Date:  2011-05-26       Impact factor: 3.046

7.  Virus reactivation: a panoramic view in human infections.

Authors:  Christopher M Traylen; Hersh R Patel; Wylder Fondaw; Sheran Mahatme; John F Williams; Lia R Walker; Ossie F Dyson; Sergio Arce; Shaw M Akula
Journal:  Future Virol       Date:  2011-04       Impact factor: 1.831

8.  Array analysis of viral gene transcription during lytic infection of cells in tissue culture with Varicella-Zoster virus.

Authors:  Randall J Cohrs; Michael P Hurley; Donald H Gilden
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

9.  The latency-associated transcript of herpes simplex virus type 1 promotes survival and stimulates axonal regeneration in sympathetic and trigeminal neurons.

Authors:  Mohamed A Hamza; Dennis M Higgins; Lawrence T Feldman; William T Ruyechan
Journal:  J Neurovirol       Date:  2007       Impact factor: 2.643

10.  A limited innate immune response is induced by a replication-defective herpes simplex virus vector following delivery to the murine central nervous system.

Authors:  Zane Zeier; J Santiago Aguilar; Cecilia M Lopez; G B Devi-Rao; Zachary L Watson; Henry V Baker; Edward K Wagner; David C Bloom
Journal:  J Neurovirol       Date:  2009-09       Impact factor: 2.643

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.